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Abstract Quantum-chemical computations were used to
investigate the structure–antioxidant parameter relation-
ships of α-lipoic acid and its natural metabolites bisnorli-
poic acid and tetranorlipoic acid in their oxidized and
reduced forms. The enantiomers of lipoic and dihydrolipoic
acid were optimized using the B3LYP/6-311+G(3df,2p),
B3LYP/aug-cc-pVDZ and MP2(full)/6-31+G(d,p) levels of
theory as isolated molecules and in the presence of water.
The geometries of the metabolites and the values of their
antioxidant parameters (proton affinity, bond dissociation
enthalpy, adiabatic ionization potential, spin density, and
the highest occupied molecular orbital energy) were
calculated at the B3LYP/6-311+G(3df,2p) level of theory.
The results obtained reveal similarities between these
structures: a pentatomic, nonaromatic ring is present in the
oxidized forms, while an unbranched aliphatic chain (as
found in saturated fatty acids) is present in both the
oxidized and the reduced forms. Analysis of the spin
density and the highest occupied molecular orbital energy
revealed that the SH groups exhibited the greatest electron-
donating activities. The values obtained for the proton
affinity, bond dissociation enthalpy and adiabatic ionization
potential indicate that the preferred antioxidant mechanisms
for α-lipoic acid and its metabolites are sequential proton
loss electron transfer in polar media and hydrogen atom
transfer in vacuum.
Keywords α-Lipoic acid . Antioxidant . Metabolites . DFT
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Introduction
α-Lipoic acid [LA, IUPAC: 5-(1,2-dithiolan-3-yl)-pentanoic
acid; 1 in Fig. 1] is an organosulfur compound that is
synthesized in small amounts by microorganisms, plants,
animals, and humans [1, 2]. It is one of the most important
cofactors of the multi-enzyme complexes in mitochondria. In
the peptide chain, LA is covalently bound to the nitrogen
atom of the lysine, forming lipoyllysine (LA-Lys; 5 in
Fig. 1). Physiological demand for LA is met by its synthesis
in every organism. While there is currently no record of a
disease caused by LA deficiency [3], the usage of LA as a
dietary supplement has recently become one of the most
popular topics in the scientific and medical worlds. The
largest amounts of LA-Lys can be found in the kidneys,
liver, heart, and in spinach and broccoli (∼1–3 μg/g) [4].
α-Lipoic acid was discovered by L.J. Reed during
studies aimed at isolating growth-stimulating factor for
Lactobacillus casei (1949–1951; note that the prefix α has
no chemical meaning, but it is helpful in distinguishing the
isolated compound from structurally related forms in
biological extracts [5]). The crystallographic structure of
LA was determined by Stroud and Carlisle 20 years later
[6]. LA is a derivative of octanoic acid with two sulfur
atoms attached to carbon atoms C6 and C8. The C6 atom is
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the chiral center of the molecule, so LA has two optical
isomers—the enantiomers R-(+)- and S-(−)- (2a and 2b in
Fig. 1, respectively)—and it also exists as a racemic
mixture (R/S-LA). However, only the R-(+)-enantiomer is
synthesized by organisms and biologically active. In its
oxidized form, LA has a characteristic pentatomic ring, as
the two sulfur atoms are connected via a disulfide bond
(S–S). The oxidized form can be reduced to an open-chain
structure with two sulfhydryl groups: dihydrolipoic acid
(DHLA; see 3 in Fig. 1). The redox pair LA/DHLA (4 in
Fig. 1) interacts with different ROSs (reactive oxygen
species), RNSs (reactive nitrogen species), as well as other
oxidants and compounds with thiol groups, such as
glutathione, cysteine, and N-acetylcysteine [7–9].
RLA is a multifunctional therapeutic compound which
has shown activity in many experimental in vitro and in
vivo studies. RLA/RDHLA is one of the strongest natural
antioxidants, and is capable of deactivating various free
radicals such as the superoxide anion (O2
•–), the hydroxyl
radical (•OH), singlet oxygen (1O2), peroxynitrite
(ONOO–), and hypochlorous acid (HClO) [10–12]. It is
also a very important regenerating factor for other anti-
oxidants: thioredoxin, vitamin E, vitamin C, and glutathi-
one (GSH) [13–16]. It has been proven that α-lipoic acid
Fig. 1 Molecular structures
of lipoic acid (1), the enan-
tiomers of lipoic acid: R-(+)-LA
(2a) and S-(−)-LA (2b),
dihydrolipoic acid (3),
the LA/DHLA redox pair (4),
and lipoyllysine (5)
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can induce GSH synthesis [17] and act as a metal-chelating
agent [18–22] and intercellular signal-transducing factor [7,
23]. RLA is viewed as a very promising therapeutic and
nutritional supplement. On the basis of clinical studies, it
was shown that adding RLA to the therapy reduces the
symptoms of rheumatoid arthritis [7], cardiovascular diseases
[24–31], diabetic polyneuropathy [32], multiple sclerosis
[33–36], and Alzheimer’s disease [7]. The biological and
therapeutical properties of RLA are dependent on its
bioavailability, tissue accumulation, and the process of
metabolization [7]. RLA and RDHLA can be β-oxidized
and/or S-methylated in cells [37, 38]. The most common
RLA/RDHLA metabolites are presented in Fig. 2.
It is well known that free radicals can be deactivated in
interactions with phenolic antioxidants via three mecha-
nisms [39]. However, due to the similarity of O–H and S–H
bonds, these processes can also be used to describe the
antioxidant action of organosulfur compounds such as α-
lipoic acid and its metabolites (Fig. 3). We can therefore
distinguish the following mechanisms of free-radical
scavenging:
1. HAT (hydrogen atom transfer) mechanism:
RSH þ X  ! RS þ XH ð1:1Þ
2. SPLET (sequential proton loss electron transfer)
mechanism:
RSH ! RS þ Hþ ð1:2Þ
RS þ X  þ Hþ ! RS þ XH ð1:3Þ
3. SET-PT (single electron transfer followed by proton
transfer) mechanism:
RSH þ X  ! RSH þ þ X ð1:4Þ
RSH þ ! RS þ Hþ: ð1:5Þ
There have been numerous publications describing exper-
imental studies of the antioxidant properties of LA/DHLA, but
this compound has not yet been investigated theoretically. In
this paper, we report our detailed analysis of several of the
molecular properties of LA/DHLA and RLA/RDHLAmetab-
olites (RBLA/RDHBLA and STLA/SDHTLA), such as their
molecular geometries and total molecular energies. We also
describe the antioxidant properties of the compounds studied,
which were derived by calculating physical antioxidant
descriptors such as the adiabatic ionization potential (AIP),
the bond dissociation enthalpy (BDE), the proton affinity
(PA), the highest occupied molecular orbital energy (EHOMO),
and the spin density (SD) [40–44]. Because the free-radical
scavenging action occurs in aqueous solution, we account for
the solvating effect of water in our quantum-mechanical
computations. Moreover, based on the calculations
performed, we predict which of the three antioxidant
mechanisms specified above is preferred for each of the
compounds studied.
Computational methods
The quantum-chemical computations were performed using
the Gaussian 03 W software package [45]. Full optimiza-
tion of the geometries and energies for all of the molecules
studied was carried out in the gas phase and in water
Fig. 3 Antioxidant mechanisms of organosulfur compounds: HAT
(1), SPLET (2), SET-PT (3). RSH organosulfur antioxidant, X• free
radical. From [39]
Fig. 2 Molecular structures of RLA/RDHLA metabolites: bisnorlipoic
acid (RBLA, 1), 4,6-bisthiohexanoic acid (RDHBLA, 2), tetranorlipoic
acid (STLA, 3), and 2,4-bisthiobutanoic acid (SDHTLA, 4)
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without symmetry constraints. The geometries of the
neutral compounds in their ground states were optimized
using DFT with the restricted rB3LYP hybrid functional
[46–48] combined with the 6-311+G(3df,2p) and aug-cc-
pVDZ basis sets. The geometry optimization of mono-, di-,
and trianions was carried out with the rB3LYP/6-311+G
(df,2p) method. To optimize the radicals and cation
radicals, the unrestricted uB3LYP/6-311+G(3df,2p) level
of theory was applied, since it gives the best results for
open-shell molecular systems. Additionally, the neutral
forms of LA and DHLA enantiomers were optimized using
second-order Møller–Plesset perturbation theory [49] com-
bined with the 6-31+G(d,p) basis set in vacuum and water.
rMP2(full)/6-31+G(d,p) was applied to achieve a better
description of electron correlation effects in the compounds
studied. Aside from analyzing the geometries, the single
point energies for RLA and SLA were calculated using
DFT and MP2(full) methods combined with a wide
spectrum of basis sets [6-31G(d,p), 6-31+G(d,p), 6-31++G
(d,p), 6-311G(d,p), 6-311+G(d,p), 6-311++G(d,p), 6-31G
(3df,2p), 6-31+G(3df,2p), 6-31++G(3df,2p), 6-311G
(3df,2p), 6-311+G(3df,2p), 6-311++G(3df,2p), cc-pVDZ,
cc-pVTZ, cc-pVQZ, aug-cc-pVDZ, and aug-cc-pVTZ] in
order to compare the energies of stereoisomers.
To establish the starting geometries of the compounds
studied and the locations of the structures with minimum
energy, a conformational analysis was performed. Rota-
tional potential energy profiles at rHF/6-31+G(d,p) for
RLA, RDHLA, SLA, and SDHLA were constructed by
scanning the internal dihedral angles (α=C1–C2–C3–C4 and
β=C3–C4–C5–C6 for LA, α=C1–C2–C3–C4 and γ=C6–C7–
C8–S1′ for DHLA) over the ranges 180°≤α≤360°,
180°≤β≤360°, 180°≤γ≤360°, with no constraint placed
on any other geometric parameter (see the “Electronic
supplementary material,” ESM). In the next step, the most
stable structures obtained from the scan were fully
optimized around each potential minimum without
symmetry constraints. For all of the optimized struc-
tures, harmonic vibrational frequencies were calculated
in order to verify the stationary points on the potential
energy surfaces (PES).
The antioxidant properties of the molecules studied were
described by calculating the numerical parameters (at
298 K) associated with their antioxidant mechanisms
Table 1 The bond lengths (in Å) and angles (in degrees) of RLA
[obtained using rMP2(full)/6-31+(d,p) and optimized in vacuum and
water] along with the experimental values from the crystallographic
structure of RLA [6]
Bond length or angle rMP2(full)/6-31+G(d,p) Experiment
Vacuum Water
C1–C2 1.50 1.50 1.50
C2–C3 1.52 1.52 1.55
C3–C4 1.52 1.52 1.53
C4–C5 1.53 1.53 1.51
C5–C6 1.52 1.52 1.53
C6–C7 1.54 1.54 1.55
C7–C8 1.54 1.54 1.51
S1′–C8 1.82 1.82 1.79
S2′–C6 1.82 1.83 1.83
S1′–S2′ 2.07 2.08 2.05
O3′–C1 1.36 1.36 1.31
O3″–C1 1.22 1.22 1.20
C1–C2–C3 113.02 113.46 112.99
C2–C3–C4 111.92 111.70 110.39
C3–C4–C5 112.17 111.93 109.28
C4–C5–C6 112.46 112.18 115.38
C5–C6–C7 113.48 113.56 112.89
C6–C7–C8 111.86 112.29 112.61
C7–C8–S1′ 109.26 109.36 112.61
C8–S1′–S2′ 90.22 109.36 95.56
C6–S2′–S1′ 90.63 90.97 92.84
C5–C6–S2′ 110.46 110.27 111.37
C7–C6–S2′ 108.17 108.28 106.76
O3′–C1–C2 111.24 111.50 113.39
O3″–C1–C2 126.16 126.09 124.89
O3′–C1–O3″ 122.60 122.41 121.89
Table 2 The bond lengths (in Å) and angles (in degrees) of RLA and
SLA [obtained using rMP2(full)/6-31+(d,p) and optimized in vacuum
and water]
Bond length or angle rMP2(full)/6-31+G(d,p)
Vacuum Water
RLA SLA RLA SLA
C6–C7 1.54 1.54 1.54 1.54
C7–C8 1.54 1.54 1.54 1.54
S1′–C8 1.82 1.82 1.82 1.82
S2′–C6 1.82 1.83 1.83 1.83
S1′–S2′ 2.07 2.07 2.08 2.08
O3′–C1 1.36 1.36 1.36 1.36
O3″–C1 1.22 1.22 1.22 1.22
C6–C7–C8 111.86 111.95 112.29 112.38
C7–C8–S1′ 109.26 109.41 109.36 109.72
C8–S1′–S2′ 90.22 90.75 90.60 91.65
S1′–S2′–C6 90.63 90.25 90.97 90.29
S2′–C6–C7 108.17 107.91 108.28 107.59
C1–C2–C3–C4 179.47 179.99 179.97 179.77
C3–C4–C5–C6 177.65 172.96 177.37 172.53
C8–S1′–S2′–C6 46.99 46.76 46.02 45.35
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(described above), such as their proton affinities (PA; the
SPLET mechanism), bond dissociation enthalpies (BDE;
the HAT mechanism), and adiabatic ionization potentials
(AIP; SET-PT mechanism) [50–55]:
PA ¼ Ha þ Hp  Hm; ð1:6:Þ
where Ha is the enthalpy of the anion, Hp is the enthalpy of
the proton, and Hm is the enthalpy of the parent molecule;
BDE ¼ Hr þ HH  Hm; ð1:7:Þ
where Hr is the enthalpy of the radical, HH is the enthalpy
of the H atom, and Hm is the enthalpy of the parent
molecule; and
AIP ¼ Ecr  Em; ð1:8:Þ
where Ecr is the total energy of the cation radical, and Em is
the total energy of the parent molecule.
In the calculations, the following enthalpy values were
used: H(H•)vacuum=−0.49764 Ha (i.e. hartrees), [42],
ΔhydrH(H
•)=−0.00152 Ha [56, 57]; H(H+)vacuum=0.00236
Ha [40]; ΔhydrH(H
+)=−0.41516 Ha [58].
Additional parameters describing the electron-donating
properties of the compounds studied (the HOMO orbital
distribution and the spin density distribution) were calcu-
lated at the B3LYP/6-311+G(3df,2p) level of theory in
vacuum and in water.
The optimizations of all forms of the compounds
investigated and the calculations of the antioxidant param-
eters in water were performed using the C-PCM solvation
model (conductor-like polarizable continuum model), [59].
In the calculations, a dielectric constant of 78.39 was used
for water. This approach was employed and described in
our previous works on the antioxidant properties of
phenolic compounds (trans-resveratrol and its derivatives)
[41, 60–62].
Fig. 4 The geometries of RLA (1), RDHLA (2), SLA (3), and
SDHLA (4) [obtained using rMP2(full)/6-31+(d,p) and optimized
in water]
Table 4 The total energy values [in Ha] of RLA and SLA [obtained





6-31G(3df,2p) −1258.253 −1258.253 0.305
6-31+G(3df,2p) −1258.275 −1258.275 0.226
6-31++G(3df,2p) −1258.276 −1258.277 0.282
6-311++G(3df,2p) −1258.810 −1258.811 0.526
cc-pVDZ −1257.728 −1257.728 0.447
cc-pVTZ −1258.507 −1258.507 0.498
cc-pVQZ −1258.877 −1258.878 0.543
aug-cc-pVDZ −1257.861 −1257.861 0.369
aug-cc-pVTZ −1258.597 −1258.597 0.474
Fig. 5 The geometries of RLA/RDHLA metabolites [obtained using
rB3LYP/6-311+G(3df,2p) and optimized in water]: RBLA (1),
RDHBLA (2), STLA (3), and SDHTLA (4)
Table 3 The bond lengths (in Å) and angles (in degrees) of RDHLA
and SDHLA [obtained using rMP2(full)/6-31+(d,p) and optimized in
vacuum and water]
Bond length or angle rMP2(full)/6-31+G(d,p)
Vacuum Water
RDHLA SDHLA RDHLA SDHLA
C6–C7 1.53 1.53 1.53 1.53
C7–C8 1.52 1.52 1.52 1.52
S1′–C8 1.83 1.82 1.83 1.82
S1′–H1′ 1.33 1.33 1.33 1.33
S2′–C6 1.83 1.83 1.83 1.83
S2′–H2′ 1.33 1.33 1.33 1.33
O3′–C1 1.36 1.36 1.36 1.36
O3″–C1 1.22 1.22 1.22 1.22
C7–C8–S1′ 110.06 108.79 110.37 108.93
C7–C6–S2′ 112.73 112.94 112.74 112.78
C6–C7–C8 116.05 114.00 116.34 113.88
C1–C2–C3–C4 179.97 179.86 179.90 179.71
C5–C6–C7–C8 176.62 175.94 177.79 174.01
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Results and discussion
The optimized geometries of LA and DHLA enantiomers
Optimizing all of the compounds’ geometries at the
rB3LYP/6-311+G(3df,2p), rB3LYP/aug-cc-pVDZ, and
rMP2(full)/6-31+(d,p) levels of theory leads to the absolute
energy minima on the potential energy surface, which is
confirmed by the absence of imaginary frequencies. The
bond lengths (in Å) and the angles (in degrees) of the
equilibrium optimized neutral structure of RLA in compar-
ison and the corresponding experimental crystallographic
data are summarized in Table 1 and Table S1 of the ESM. It
should be pointed out, that regardless of the method and
basis set used, the equilibrium values of geometrical
parameters are almost identical and very similar to the
results obtained by Stroud and Carlisle (1972) for the
crystallographic structure of LA [6]. Additionally, the
results presented in Tables 2 and 3 and Tables S2 and S3
of the ESM reveal that there are no geometric differences
between enantiomers (RLA and SLA; RDHLA and
SDHLA, see Fig. 4), which is in good agreement with the
statement that optical isomers are like mirror images of
each other. The analysis of ΔEtotal for RLA and SLA, as
calculated using DFT and MP2(full) employing a wide
range of basis sets (Table 4 and Table S4 of the ESM),
confirms that the enantiomers are isoenergetic structures.
The optimized geometries of RLA/RDHLA metabolites
Optimization of the geometries of the metabolites was
performed at the rB3LYP/6-311+G(3df,2p) level of theory
in vacuum and water. The equilibrium geometries (Fig. 5)
are at the absolute energy minima on the potential energy
surface, as confirmed by the absence of imaginary
frequencies. A comparative analysis of the geometrical
parameters in vacuum (Table S5 of the ESM) and in water
(Table S6 of the ESM) reveals that there is good agreement
between the molecular structures of RLA, RDHLA, and
their metabolites. All of the compounds studied demon-
strate similarities in the geometry of the aliphatic chain. The
values of the dihedral angle C*–S1′–S2′–C* in the cyclic
forms (where C* has a different number in each cyclic
form) indicate that the pentatomic ring is not a planar
system but has the conformation of an envelope. The 1′-S–H
and 2′-S–H bond lengths of the reduced forms are practically
identical in both vacuum and water, which indicates a lack of
influence of solvation effects.
Table 5 The AIP (in
kcal mol−1) and ΔAIP (in
kcal mol−1) values [calculated at
the B3LYP/6-311+G(3df,2p)




AIP (kcal/mol) ΔAIP (kcal/mol) AIP (kcal/mol) ΔAIP (kcal/mol)
RLA 171 0 131 0
SLA 171 0 131 0
RDHLA 193 22 159 28
SDHLA 191 21 157 26
RBLA 173 2 132 1
RDHBLA 195 24 158 27
STLA 193 22 128 −3
SDHTLA 199 28 162 31
Table 6 The BDE (in
kcal mol−1) and ΔBDE (in
kcal mol−1) values [calculated at
the B3LYP/6-311+G(3df,2p)




BDE (in kcal/mol) ΔBDE (in kcal/mol) BDE (in kcal/mol) ΔBDE
(in kcal/mol)
1′-SH–RDHBLA 86 1 96 1
1′-SH–RDHLA 85 0 96 0
1′-SH–SDHLA 85 0 95 0
1′-SH–SDHTLA 85 1 96 1
2′-SH–RDHBLA 85 1 97 1
2′-SH–RDHLA 86 1 96 1
2′-SH–SDHLA 86 2 97 2
2′-SH–SDHTLA 87 2 97 2
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AIP, BDE, PA, spin density, and HOMO orbital distribution
AIP is a very important physical property that describes the
process of single electron donation by the antioxidant. The
smaller the AIP value, the greater the chance that ionization
will occur. Molecules with low AIP values are considered very
good antioxidants. Calculations (Table 5) indicate that the
lowest values of AIP in both vacuum and water media are
associated with oxidized forms: RLA, RBLA, STLA (in order
of increasing AIP) in vacuum and STLA, RLA, RBLA (in
order of increasing AIP) in water. In vacuum, the same order
can be ascribed to the reduced forms: RDHLA, RDHBLA,
SDHTLA, but in water, we observe the following growing
order: RDHBLA, RDHLA, SDHTLA. The AIP values in
water are lower than in vacuum for all of the compounds
studied. This is connected to the strong electrostatic interac-
tion of the polar medium with cation radical forms. Because
AIP represents the SET-PT mechanism, it is possible that this
mechanism is more preferable in water than in vacuum.
The stability of the S–H bond can be evaluated using a
thermodynamic parameter, the homolytic BDE. Hydrogen
atom transfer from antioxidant to radical is a possible
antioxidant mechanism. Because the reduced forms of the
compounds studied have two S–H bonds, we have taken
into consideration all possible reactions. The calculated
values of the BDE are presented in Table 6. Based on the
results obtained, it is clear that RDHLA and its metabolites
have similar S–H bond stabilities. Just as for the AIP results
(Table 5), there are no differences between the DHLA
stereoisomers in vacuum and in water. In water, the S–H
bond is less prone to homolytic fission than in vacuum,
because of higher BDE values. This means that the
HAT mechanism is not preferable in a polar medium for
the compounds studied. Hydrogen atom transfer is
hindered because a polar medium increases the stability
of S–H bonds.
The PA values were calculated for the neutral forms of
RDHLA, RDHBLA, and SDHTLA, as well as for their 3′-
Table 7 The PA (in kcal mol−1)
and ΔPA (in kcal mol−1) values
[calculated at the rB3LYP/6-311+
G(3df,2p) level in vacuum and
water] of the neutral, mono-, and
dianionic forms of RDHLA and
its metabolites
Compound 1′-S–H 2′-S–H
Vacuum Water Vacuum Water
PA ΔPA PA ΔPA PA ΔPA PA ΔPA
RDHLA 344 0 34 0 342 0 44 0
RDHBLA 350 6 23 −11 341 −1 32 −11
SDHTLA 349 4 33 0 339 −3 29 −15
3′-O-mRDHLA 384 40 34 0 388 46 34 −10
3′-O-mRDHBLA 398 53 25 −8 408 66 26 −17
3′-O-mSDHTLA 414 70 27 −7 434 92 28 −16
2′-S,3′-O-dRDHLA 458 113 36 2 − − − −
1′-S,3′-O-dRDHLA − − − − 461 120 37 −7
2′-S,3′-O-dRDHBLA 466 122 37 3 − − − −
1′-S,3′-O-dRDHBLA − − − − 476 135 38 −6
2′-S,3′-O-dSDHTLA 481 137 37 3 − − − −
1′-S,3′-O-dSDHTLA − − − − 501 160 38 −6
Table 8 The spin density (SD)
values [calculated at the
uB3LYP/6-311+G(3df,2p) level




S1′ S2′ O3′ O3″ S1′ S2′ O3′ O3″
1′-S-RDHBLA 1.0662 0.0137 −0.0002 0.0000 1.0700 0.0149 −0.0002 0.0000
1′-S-RDHLA 1.0487 0.0033 0.0000 0.0000 1.0642 0.0045 0.0000 0.0000
1′-S-SDHLA 1.0796 0.0084 0.0000 0.0000 1.0830 0.0080 0.0000 0.0000
1′-S-SDHTLA 1.0522 0.0116 −0.0001 0.0001 1.0569 0.0110 −0.0002 0.0000
2′-S-RDHBLA −0.0042 1.0496 0.0002 0.0000 −0.0064 1.0540 0.0002 −0.0001
2′-S-RDHLA 0.0041 1.0611 0.0000 0.0001 0.0032 1.0693 0.0001 0.0001
2′-S-SDHLA −0.0088 1.0560 0.0000 0.0001 0.0163 1.0397 0.0001 0.0003
2′-S-SDHTLA 0.0011 1.0313 0.0031 0.0147 0.0005 1.0349 0.0024 0.0130
J Mol Model (2012) 18:2907–2916 2913
O-monoanions, 1′-S,3′-O-dianions, and 2′-S,3′-O-dianions.
The results obtained are presented in Table 7. For all of the
compounds studied, the PA values in water are much
smaller than those in vacuum, which means that in a polar
medium the SPLET mechanism is greatly preferred.
Turning our attention to the ΔPA values, we notice that
S–H bonds in the monoanions and dianions are more prone
to heterolytic fission than those in neutral forms. The higher
PA values observed for the 2′-S–H bond than for the 1′-S–H
bond suggest that the former break more easily.
Upon comparing the AIP, PA, and BDE values for all of
the compounds studied, it is clear that the preferred
antioxidant pathway in a polar medium for lipoic acid and
its metabolites is the SPLET mechanism. The HAT
mechanism is preferred in nonpolar media.
When describing the free-radical scavenging activities of
molecules, parameters such as the spin density (SD)
distribution in free radicals and the energy of the HOMO
orbital are also useful. The SD has been calculated for the
1′-S- and 2′-S-radicals of RDHLA, SDHLA, RDHBLA,
and SDHTLA. According to these calculations (Table 8),
the highest concentration of SD is observed for the S1′ atom
in 1′-S-radicals and for S2′ in 2′-S-radicals. In comparison,
the SD values for the O3′ and O3″ atoms in these radicals
are very small, which proves the absence of electron
delocalization through the whole molecule. The SD values
in water are slightly higher than those in vacuum for all of
the radicals studied (Table 8). We can therefore conclude
that the antioxidant mechanisms involving radical action
are not preferred in polar media. The energy of the HOMO
orbital is another important molecular parameter associated
with the scavenging of free radicals. Molecules with higher
EHOMO values have stronger electron-donating abilities. All
of the compounds studied have similar values of EHOMO
(Table 9). The electronic density distribution in these
orbitals is concentrated on the sulfur atoms (Fig. 6). Similar
to the SD distribution, there is no delocalization of HOMO
orbitals. It can be predicted that S–S and S–H bonds are the
most probable sites of free-radical attack in all of the
molecules studied.
Conclusions
Structure–antioxidant parameter relationships of α-lipoic
acid and its natural metabolites bisnorlipoic acid and
tetranorlipoic acid in their oxidized and reduced forms
have been investigated using quantum-chemical methods:
DFT/B3LYP and MP2(full). On the basis of the results
obtained, we can confirm that the SH groups of the reduced
Table 9 The HOMO orbital distributions (EHOMO and ΔEHOMO) of LA/DHLA enantiomers and RLA/RDHLA metabolites [obtained using
rB3LYP/6-311+G(3df,2p) and optimized in vacuum and water]
Compounds Vacuum Water
EHOMO (Ha) EHOMO (eV) ΔEHOMO (eV) EHOMO (Ha) EHOMO (eV) ΔEHOMO (eV)
RLA −0.215 −5.9 0.0 −0.211 −5.7 0.0
SLA −0.214 −5.8 0.0 −0.212 −5.8 0.0
RDHLA −0.245 −6.7 0.8 −0.240 −6.5 0.8
SDHLA −0.244 −6.6 0.8 −0.241 −6.5 0.8
RBLA −0.218 −5.9 0.1 −0.212 −5.8 0.0
RDHBLA −0.246 −6.7 0.8 −0.247 −6.7 1.0
STLA −0.220 −6.0 0.1 −0.220 −6.0 0.3
SDHTLA −0.249 −6.8 0.9 −0.246 −6.7 0.9
Fig. 6 The HOMO orbital distributions in RLA (1), SLA (2),
RDHLA (3), SDHLA (4), RBLA (5), RDHBLA (6), STLA (7), and
SDHTLA (8). The calculations were accomplished in vacuum with the
isovalue 0.07
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forms are responsible for their antioxidant properties. More
importantly, we propose that the most preferable antioxidant
mechanism in polar media is SPLET. However, in nonpolar
media, the HAT mechanism is preferred, as shown by
calculations performed for isolated molecules. α-Lipoic acid
and its natural metabolites are not the only available organo-
sulfur acids that act as antioxidants; LA/DHLA derivatives
should also be included in quantum-chemical investigations.
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